Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Be the Match® Patient Support Center Survey; OMB No. 0906-0004-Revision, 53009-53011 [2020-18895]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 167 / Thursday, August 27, 2020 / Notices
20857, 301–443–7526, aianhealth@
hrsa.gov.
SUPPLEMENTARY INFORMATION: The HRSA
TAC will be established to engage in
regular and meaningful collaboration
and consultation with tribal officials on
policies that have tribal implications
and substantial direct effect on Indian
tribes. HRSA, an agency of the U.S.
Department of Health and Human
Services (HHS), is the primary federal
agency for improving health care to
people who are geographically isolated,
and/or economically or medically
vulnerable. This includes people living
with HIV/AIDS; pregnant women,
mothers, and their families; and those
otherwise unable to access high-quality
health care. HRSA supports the training
of health professionals, the distribution
of providers to areas where they are
needed most, and improvements in
health care delivery. HRSA also
oversees organ, bone marrow, and cord
blood donation. It also oversees the
National Vaccine Injury Compensation
Program which can provide
compensation to individuals in the rare
cases that they are harmed by certain
covered vaccinations and maintains
databases that flag providers with a
record of health care malpractice, waste,
fraud, and abuse for federal, state, and
local use.
The HRSA TAC will be the vehicle for
acquiring a broad range of tribal views,
determining the impact of HRSA
programs on the American Indian and
Alaska Natives health systems and
population, developing innovative
approaches to deliver health care, and
assisting with effective tribal
consultation. The HRSA TAC will hold
one meeting each calendar year, or at
the discretion of HRSA in consultation
with the Chair. These meetings may be
held in-person or virtually. The HRSA
TAC will support, not supplant, any
other government-to-government
consultation activities that HRSA
undertakes. In addition to assisting
HRSA in the planning and coordination
of tribal consultation sessions, the
HRSA TAC will advise HRSA regarding
the government-togovernment
consultation process and will help
ensure that HRSA activities and policies
that impact Indian country are brought
to the attention of all tribal leaders.
Nominations: A previous notice
regarding the HRSA TAC was published
in the Federal Register on February 6,
2020. The deadline for submissions was
extended to July 6, 2020, and while
HRSA received additional nomination
packets, it did not receive a sufficient
number of nomination packets to
consider for each of the 12 vacant
VerDate Sep<11>2014
17:09 Aug 26, 2020
Jkt 250001
positions. HRSA is requesting
nominations of tribal officials to serve as
HRSA TAC delegate members to fill up
to 12 voluntary positions on the HRSA
TAC; one authorized tribal
representative (and one designated
alternate) from each of the Indian Health
Service geographic areas. HRSA
continues to seek additional qualified
nominees, specifically from eligible
tribal officials from the IHS geographic
areas of: Alaska; Albuquerque; Billings;
Navajo; Phoenix; and Tucson. The
HRSA Administrator will appoint HRSA
TAC delegate members with the
expertise needed to fulfill the duties of
the Advisory Council. Nominees will be
considered in the following priority
order:
1. Tribal president, chairperson, or
governor;
2. Tribal vice president, vicechairperson, or lieutenant governor;
3. Elected or appointed tribal official;
and
4. Designated tribal official.
Interested applicants may selfnominate or be nominated by another
individual or organization.
Individuals selected for appointment
to the HRSA TAC will be invited to
serve terms of up to 2 years. Appointed
delegate members will receive per diem
and travel expenses incurred for
attending HRSA TAC meetings and/or
conducting other authorized and
approved business on behalf of the
HRSA TAC.
The following information must be
included in the package of materials
submitted for each individual
nominated for consideration: (1) Name
of the nominee, a description of the
interests the nominee would represent,
and a description of the nominee’s
experience and interest in American
Indian and Alaska Native access to
health care; (2) evidence that the
nominee is a duly elected or appointed
tribal leader or tribal officer, or has been
designated with authority to act on
behalf of the duly elected or appointed
tribal leader or officer, and is authorized
to represent a tribal government; (3) a
written commitment from the nominee
that they will actively participate in
good faith in HRSA TAC meetings; and
(4) a current copy of the nominee’s
curriculum vitae. Nomination packages
may be submitted directly by the
individual being nominated or by the
person/organization recommending the
candidate.
HHS endeavors to ensure that the
membership of the HRSA TAC is fairly
balanced in terms of points of view
represented and that individuals from a
broad representation of geographic
areas, gender, and ethnic and minority
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
53009
groups, as well as individuals with
disabilities, are considered for
membership. Appointments shall be
made without discrimination on the
basis of age, ethnicity, gender, sexual
orientation, or cultural, religious, or
socioeconomic status.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020–18865 Filed 8–26–20; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request; Information
Collection Request Title: Be the
Match® Patient Support Center Survey;
OMB No. 0906–0004—Revision
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
AGENCY:
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995,
HRSA submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period. OMB may act on
HRSA’s ICR only after the 30 day
comment period for this notice has
closed.
SUMMARY:
Comments on this ICR should be
received no later than September 28,
2020.
DATES:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under Review—Open for
Public Comments’’ or by using the
search function.
ADDRESSES:
To
request a copy of the clearance requests
submitted to OMB for review, email Lisa
Wright-Solomon, the HRSA Information
Collection Clearance Officer at
paperwork@hrsa.gov or call (301) 443–
1984.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\27AUN1.SGM
27AUN1
53010
Federal Register / Vol. 85, No. 167 / Thursday, August 27, 2020 / Notices
Information Collection Request Title:
Be the Match® Patient Support Center
Survey OMB No. 0906–0004—Revision.
Abstract: The C.W. Bill Young Cell
Transplantation Program (Program) was
established by the Stem Cell
Therapeutic and Research Act of 2005
(Public Law 109–129), as amended. The
Program’s Office of Patient Advocacy is
operated by the National Marrow Donor
Program® (NMDP)/Be The Match®.
NMDP/Be The Match® has specific
requirements under its HRSA contract
to conduct surveys to assess patient
satisfaction. As such, NMDP/Be The
Match® will elicit feedback from
marrow and cord blood transplant
patients, caregivers, and family
members who had contact with the Be
The Match® Patient Support Center for
navigation services, educational
information, and support. The survey
also includes demographic questions to
determine the representativeness of
findings. The objectives of the survey
are to: (1) Determine the level of
satisfaction with existing services of the
Patient Support Center and (2)
determine areas for improvement as
well as opportunities for the
development of new programs and
services.
A 60-day notice published in the
Federal Register on May 4, 2020, Vol.
85, No. 86; pp. 26483–84. There were no
public comments.
The number of respondents figure
published in the 60-day notice reflected
the total surveys to be distributed and
not the total respondents. This
decreases the number of respondents
from 4,000 to 1,320, and the burden
hours from 680 to 220. The NMDP used
new data to more accurately assess
response rates based on past experience.
NMDP also simplified its survey tool
and aligned key metrics asked in the
survey (Net Promoter Score) with
industry evaluation standards and best
practices to enhance the quality, utility,
and clarity of the information collected.
The NMDP has also minimized the
collection burden by using the Qualtrics
software platform to transmit the
surveys and automated reminders.
Need and Proposed Use of the
Information: Barriers restricting access
to transplant-related care and
educational information are multifactorial. Feedback from participants is
essential to understand the changing
needs for services, and information, as
well as to demonstrate the effectiveness
of existing services. The primary use for
information gathered through the survey
is to determine the helpfulness of
participants’ initial contact with the Be
The Match® Blood and Marrow
Transplant (BMT) Navigators and to
identify areas for improvement in the
delivery of services. The BMT
Navigators are Certified Oncology
Patients or Nurse Navigators, who
respond to requests for information and
support. Stakeholders (e.g., participants,
program managers, Be The Match®
leadership, and HRSA) use this
evaluation data to share patients’
experiences as well as make program
decisions (by program managers and
leadership) and resource allocation
decisions (by HRSA).
Online and paper-based surveys will
be administered to all participants
(patients, caregivers, and family
members) who have contact with the Be
The Match® Patient Support Center. All
participants that provided an email
address will be invited to complete the
survey online. All other participants
will be mailed a survey with a pre-paid
reply envelope. Survey respondents will
be notified via email and cover letter
and informed in the survey instructions
that participation is voluntary, and
responses will be kept confidential. A
follow-up notification will be sent
within two (2) weeks to nonrespondents. The survey will be
available in English and Spanish
versions.
The survey will measure: (1) Overall
satisfaction; (2) if the contact helped the
participant feel more confident in
coping with the area of concern
regarding the call; (3) if the contact
helped the participant feel more
hopeful; (4) if the contact helped the
participant feel less alone; (5) if the
contact increased awareness of available
resources; (6) if the contact helped the
participant feel more informed about
treatment options; (7) if participant’s
questions were answered through
contact with the Be The Match® Patient
Support Center, and (8) types of
challenges faced by participant. The
survey data will be analyzed quarterly
and rolled up for an annualized
analysis. The results of the analyses will
be shared with program managers and
HRSA. Feedback indicating a need for
improvement will be reviewed by
program managers biannually, and
implementation of results, program
changes, or additions will be
documented.
Proposed changes to the survey
instrument include minor changes to
selected questions and a reduction in
the overall number of questions. The
estimated amount of respondents will
increase as it will be easier for them to
complete the survey online. As a result
of fewer questions along with the
addition of an online platform, the
respondent’s burden will decrease.
Likely Respondents: Respondents will
include all patients, caregivers, and
family members who have contact with
Be The Match® Patient Services
Coordinators via phone or email for
transplant navigation services and
support. The decision to survey all
participants was made based on
historical evidence of patients’
unavailability due to frequent
transitions in health status.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information as well as
disclosing and providing information; to
train personnel and to be able to
respond to a collection of information;
to search data sources; to complete and
review the collection of information;
and to transmit or otherwise disclose
the information. The total annual
burden hours estimated for this ICR are
summarized in the table below.
khammond on DSKJM1Z7X2PROD with NOTICES
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Number of
respondents
Number of
responses per
rspondent
Total
responses
Average
burden per
response
(in hours)
Total
burden
hours
Be The Match® Patient Services Survey ..............................................................
1,320
1
1,320
0.167*
220**
* Decreased from .25 average burden per response as published in the May 4, 2020 60-day FRN.
** Decreased from 680 total burden hours as published in the May 4, 2020 60-day FRN due to a reduction in the estimated number of respondents.
VerDate Sep<11>2014
17:09 Aug 26, 2020
Jkt 250001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
E:\FR\FM\27AUN1.SGM
27AUN1
Federal Register / Vol. 85, No. 167 / Thursday, August 27, 2020 / Notices
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; COVID-related CCIA
Applications (U01/R21).
Date: September 25, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1073, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Center for
Advancing Translational Sciences, National
Institutes of Health, 6701 Democracy
Boulevard, Room 1073, Bethesda, MD 20892,
(301) 435–1348, livingsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
VerDate Sep<11>2014
17:09 Aug 26, 2020
Jkt 250001
Dated: August 24, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
[FR Doc. 2020–18882 Filed 8–26–20; 8:45 am]
Dated: August 21, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–18817 Filed 8–26–20; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
[FR Doc. 2020–18895 Filed 8–26–20; 8:45 am]
53011
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel. The meetings
will be closed to the public in
accordance with the provisions set forth
in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review
C–SEP.
Date: September 30, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Institutional
Training Program (T32) Review SEP.
Date: October 23, 2020.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy Plaza,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3398, hayesj@mail.nih.gov.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; NIDCR Clinical Studies SEP.
Date: October 7, 2020.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
670, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yun Mei, MD, Scientific
Review Officer, Scientific Review Branch,
National Institute of Dental and Craniofacial
Research, National Institutes of Health, 6701
Democracy Boulevard, Suite 670, Bethesda,
MD 20892, (301) 827–4639, yun.mei@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: August 24, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–18880 Filed 8–26–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\27AUN1.SGM
27AUN1
]]>Agencies
[Federal Register Volume 85, Number 167 (Thursday, August 27, 2020)]
[Notices]
[Pages 53009-53011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18895]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Public Comment Request; Information Collection Request Title: Be the
Match[supreg] Patient Support Center Survey; OMB No. 0906-0004--
Revision
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, HRSA
submitted an Information Collection Request (ICR) to the Office of
Management and Budget (OMB) for review and approval. Comments submitted
during the first public review of this ICR will be provided to OMB. OMB
will accept further comments from the public during the review and
approval period. OMB may act on HRSA's ICR only after the 30 day
comment period for this notice has closed.
DATES: Comments on this ICR should be received no later than September
28, 2020.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under Review--Open for
Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email Lisa Wright-Solomon, the
HRSA Information Collection Clearance Officer at [email protected] or
call (301) 443-1984.
SUPPLEMENTARY INFORMATION:
[[Page 53010]]
Information Collection Request Title: Be the Match[supreg] Patient
Support Center Survey OMB No. 0906-0004--Revision.
Abstract: The C.W. Bill Young Cell Transplantation Program
(Program) was established by the Stem Cell Therapeutic and Research Act
of 2005 (Public Law 109-129), as amended. The Program's Office of
Patient Advocacy is operated by the National Marrow Donor
Program[supreg] (NMDP)/Be The Match[supreg]. NMDP/Be The Match[supreg]
has specific requirements under its HRSA contract to conduct surveys to
assess patient satisfaction. As such, NMDP/Be The Match[supreg] will
elicit feedback from marrow and cord blood transplant patients,
caregivers, and family members who had contact with the Be The
Match[supreg] Patient Support Center for navigation services,
educational information, and support. The survey also includes
demographic questions to determine the representativeness of findings.
The objectives of the survey are to: (1) Determine the level of
satisfaction with existing services of the Patient Support Center and
(2) determine areas for improvement as well as opportunities for the
development of new programs and services.
A 60-day notice published in the Federal Register on May 4, 2020,
Vol. 85, No. 86; pp. 26483-84. There were no public comments.
The number of respondents figure published in the 60-day notice
reflected the total surveys to be distributed and not the total
respondents. This decreases the number of respondents from 4,000 to
1,320, and the burden hours from 680 to 220. The NMDP used new data to
more accurately assess response rates based on past experience. NMDP
also simplified its survey tool and aligned key metrics asked in the
survey (Net Promoter Score) with industry evaluation standards and best
practices to enhance the quality, utility, and clarity of the
information collected. The NMDP has also minimized the collection
burden by using the Qualtrics software platform to transmit the surveys
and automated reminders.
Need and Proposed Use of the Information: Barriers restricting
access to transplant-related care and educational information are
multi-factorial. Feedback from participants is essential to understand
the changing needs for services, and information, as well as to
demonstrate the effectiveness of existing services. The primary use for
information gathered through the survey is to determine the helpfulness
of participants' initial contact with the Be The Match[supreg] Blood
and Marrow Transplant (BMT) Navigators and to identify areas for
improvement in the delivery of services. The BMT Navigators are
Certified Oncology Patients or Nurse Navigators, who respond to
requests for information and support. Stakeholders (e.g., participants,
program managers, Be The Match[supreg] leadership, and HRSA) use this
evaluation data to share patients' experiences as well as make program
decisions (by program managers and leadership) and resource allocation
decisions (by HRSA).
Online and paper-based surveys will be administered to all
participants (patients, caregivers, and family members) who have
contact with the Be The Match[supreg] Patient Support Center. All
participants that provided an email address will be invited to complete
the survey online. All other participants will be mailed a survey with
a pre-paid reply envelope. Survey respondents will be notified via
email and cover letter and informed in the survey instructions that
participation is voluntary, and responses will be kept confidential. A
follow-up notification will be sent within two (2) weeks to non-
respondents. The survey will be available in English and Spanish
versions.
The survey will measure: (1) Overall satisfaction; (2) if the
contact helped the participant feel more confident in coping with the
area of concern regarding the call; (3) if the contact helped the
participant feel more hopeful; (4) if the contact helped the
participant feel less alone; (5) if the contact increased awareness of
available resources; (6) if the contact helped the participant feel
more informed about treatment options; (7) if participant's questions
were answered through contact with the Be The Match[supreg] Patient
Support Center, and (8) types of challenges faced by participant. The
survey data will be analyzed quarterly and rolled up for an annualized
analysis. The results of the analyses will be shared with program
managers and HRSA. Feedback indicating a need for improvement will be
reviewed by program managers biannually, and implementation of results,
program changes, or additions will be documented.
Proposed changes to the survey instrument include minor changes to
selected questions and a reduction in the overall number of questions.
The estimated amount of respondents will increase as it will be easier
for them to complete the survey online. As a result of fewer questions
along with the addition of an online platform, the respondent's burden
will decrease.
Likely Respondents: Respondents will include all patients,
caregivers, and family members who have contact with Be The
Match[supreg] Patient Services Coordinators via phone or email for
transplant navigation services and support. The decision to survey all
participants was made based on historical evidence of patients'
unavailability due to frequent transitions in health status.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating, and verifying
information, processing and maintaining information as well as
disclosing and providing information; to train personnel and to be able
to respond to a collection of information; to search data sources; to
complete and review the collection of information; and to transmit or
otherwise disclose the information. The total annual burden hours
estimated for this ICR are summarized in the table below.
Total Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents rspondent responses (in hours) hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Be The Match[supreg] Patient Services Survey....................... 1,320 1 1,320 0.167* 220**
--------------------------------------------------------------------------------------------------------------------------------------------------------
* Decreased from .25 average burden per response as published in the May 4, 2020 60-day FRN.
** Decreased from 680 total burden hours as published in the May 4, 2020 60-day FRN due to a reduction in the estimated number of respondents.
[[Page 53011]]
HRSA specifically requests comments on (1) the necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2020-18895 Filed 8-26-20; 8:45 am]
BILLING CODE 4165-15-P
